Low-Code Estate Board Adviser

The mandate

Business teams have created thousands of low-code applications for study coordination, quality events, plant scheduling and field engagement, often faster than central technology could respond. The estate now includes regulated records, unowned integrations, privileged connectors and applications whose creators have moved roles. The board’s recurring question is how to preserve valuable local problem-solving while eliminating unsupported operational dependency, validation ambiguity and concentration in a platform whose commercial terms are changing.

The adviser will examine monthly portfolio and control evidence, meet platform and business owners before committees, attend four Geneva sessions and observe one regulated workflow. The cadence will challenge application criticality, creator competence, data and connector use, lifecycle ownership, validation, support, reuse, retirement and vendor exit. Advice will distinguish proportionate governance from a blanket shutdown likely to drive sensitive work back into spreadsheets and email.

The appointment runs for ten months through the annual platform renewal and two estate disposition cycles. Any extension requires an explicit committee decision showing a new governance question after management has classified priority applications and established sustainable ownership for regulated use. The advisory need should close when ordinary executives can make retire, rebuild, formalise and tolerate decisions without relying on external classification.

No line authority or executive responsibility belongs to the adviser for application operation, quality validation, cyber acceptance, platform licensing, workforce access, data governance or investment. Business and technology officers retain those decisions. The adviser can challenge an ownerless workflow and record dissent but cannot certify an application, direct a maker or act as the platform product executive.

Conflicts and disclosures include low-code vendors, service partners, pharmaceutical companies, validation firms, cyber providers and relevant investors. Supplier-specific recusal applies when independence could be questioned. The adviser may not recommend an implementation partner for compensation, pursue the resulting remediation programme or remove confidential application and clinical-process information from approved client systems.

Why the board wants this voice

Platform advocates point to delivery speed, control teams point to unmanaged risk and business units point to central backlogs; all three are partly correct. Current governance debates therefore oscillate between permissive growth and central prohibition. The board wants an experienced enterprise-platform voice who can segment by consequence, expose the true operating owner and evaluate vendor dependency without extinguishing the local capability that created useful solutions.

What you will own

• Challenge application classification by process consequence, data sensitivity, regulatory use, integration privilege, scale and recoverability.
• Examine whether named business and technology owners understand operation, change, incident, continuity, validation and retirement obligations.
• Test maker and reviewer competency models against the complexity and consequence of applications they are permitted to create.
• Assess platform concentration through exportability, connector dependence, proprietary logic, licence change and alternative operating routes.
• Frame disposition choices to tolerate, formalise, rebuild, consolidate or retire with migration and workflow-continuity implications explicit.
• Review estate measures for criticality, owner coverage, unsupported components, incidents, reuse, retirement and hidden central support.
• Leave directors a proportionate challenge model that protects regulated records while preserving low-risk local innovation.

Candidate qualifications

• Has governed a large low-code or citizen-development estate inside pharmaceutical, healthcare or another validated environment.
• Can distinguish useful local automation from a regulated application requiring formal lifecycle, evidence and operational ownership.
• Understands connector privilege, embedded logic, data movement, maker succession, validation and platform concentration risk.
• Has rationalised an estate without forcing teams back into uncontrolled spreadsheets, macros or unapproved shadow services.
• Can challenge both vendor-led democratisation claims and control-led prohibition using segmented operational evidence.
• Advises boards while preserving formal quality, security, data and investment authority with designated client officers.

Non-negotiables

• Can attend all four Geneva sessions and the planned regulated-workflow walkthrough during the ten-month appointment.
• Will disclose interests involving low-code vendors, service firms, validation providers, pharmaceutical companies and investors.
• Brings citizen-development governance in regulated operations; collaboration tooling or generic application inventory is insufficient.
• Will not certify applications, endorse suppliers or seek downstream estate-remediation work arising from the review.

1. 49 words maximum. Which low-code workflow characteristic most changes its required governance tier?
2. 49 words maximum. How would you retire an ownerless regulated application without driving work into spreadsheets?
3. 49 words maximum. What vendor-dependency proof would you demand before the platform renewal decision?